| Line Item | 2022-04-29 | Y/Y |
|---|---|---|
| Revenue | $31.69B | +5.2% |
| Cost of Revenue | $10.14B | -3.2% |
| R&D Expense | $2.75B | +10.1% |
| SG&A Expense | $10.29B | +1.4% |
| Operating Income | $5.75B | +28.3% |
| Interest Expense | $553.0M | -40.2% |
| Pre-tax Income | $5.52B | +41.6% |
| Income Tax | $456.0M | +72.1% |
| Net Income | $5.04B |
| Line Item | 2022-04-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.71B | +3.4% |
| Short-term Investments | $6.86B | -5.1% |
| Accounts Receivable | $5.55B | +1.6% |
| Inventory | $4.62B | +7.0% |
| Current Assets | $23.06B | +2.3% |
| Total Assets | $90.98B | -2.3% |
| Current Liabilities | $12.39B | +45.7% |
| Line Item | 2022-04-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.35B | +17.7% |
| Capital Expenditures | $1.37B | +1.0% |
| Investing Cash Flow | -$1.66B | +42.1% |
| Financing Cash Flow | -$5.34B | -29.0% |
| Free Cash Flow | $5.98B | +22.4% |
| +39.7% |
| EPS (Basic) | $3.75 | +39.9% |
| EPS (Diluted) | $3.73 | +40.2% |
| Long-term Debt |
| $20.37B |
| -22.8% |
| Total Liabilities | $38.26B | -7.8% |
| Stockholders' Equity | $52.55B | +2.2% |